Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New FDA Clinical Trial for Female Hair Loss Sufferers – Participants Eligible to Receive Complimentary LaserCap
  • USA - English


News provided by

Bauman Medical Group

May 28, 2015, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Alan J. Bauman, M.D.
Alan J. Bauman, M.D.

Boca Raton, FL (PRWEB) May 28, 2015 -- Women suffering from hair loss or hair thinning have a rare opportunity to participate in an FDA clinical trial under the direct supervision of Alan J. Bauman, M.D., one of the nation’s leading hair restoration physicians. Dr. Bauman is conducting this clinical trial on behalf of LaserCap and is seeking women between the ages of 40 and 60, who may be noticing thinner, wispier hair, a smaller ponytail volume, decreasing scalp coverage, a wider part-line or excessive shedding hair in their brush or sink. Men are also invited to participate.

Dr. Bauman is conducting a clinical trial on behalf of LaserCap and is seeking women between the ages of 40 and 60.

Post this

Invented by Dr. Michael Rabin of Transdermal Cap, Inc., LaserCap provides low level laser therapy to the scalp in a powerful, portable, rechargeable, discreet hands-free device that fits completely under a standard baseball hat. Low level laser therapy has been used in the United States for more than 20 years in the treatment of hair loss with numerous devices achieving FDA clearance for hair growth in recent years. Transdermal Cap, Inc. has engaged the services of the Bauman Medical Consulting Division to perform this double blind, randomized, IRB-reviewed and approved research trial on behalf of the company. The LaserCap trial will be performed with IRB-approved protocols in the pursuit of an FDA 510(k) clearance for the safe and effective use of LaserCap for the treatment of female androgenetic alopecia, hereditary hair loss.

The Bauman Medical Consulting Division conducts clinical trials for some of the world’s largest companies, including most recently Procter & Gamble, regarding their new over-the-counter cosmetic “hair thickening treatment.” That research study resulted in the worldwide launch in 2013 of a P&G product under Pantene’s Expert Collection line (also known as Clinicare in Asia), called “AgeDefy Hair Thickening Treatment” that is presently available in retail stores nationwide. Dr. Bauman was designated a Chief Medical Spokesperson for P&G when launching the Pantene “AgeDefy Daily Hair Thickening Treatment” product globally and presented his research in launch events in Beijing, São Paulo, Edinburgh, Boca Raton, New York, and others. Dr. Bauman has also served on the prestigious international Pantene-ProV Hair Research Institute. Click here for more info about the Bauman Medical Group Consulting Division; click here to learn more about Pantene Expert Collection “AgeDefy” Hair Thickening Treatment.

LaserCap Eligibility:

Eligible candidates will receive a LaserCap* which is up to three times more powerful than a commercial-grade in office unit and up to 40 times more powerful than other consumer lasers. The LaserCap is embedded with more than 220 light emitting diodes that bathe the entire scalp in light, potentially stimulating hair growth and preserving hair follicles through a process called photobiomodulation, increasing blood flow and cellular energy production encouraging hair follicles to produce thicker, shinier, fuller looking hair. The trial requires two office visits, once to receive the LaserCap and the second time 16 weeks later at the conclusion of the trial. At the end of the trial, all participants will receive a brand new LaserCap (a $2,999 value) at no cost. Women, or men, interested in participating in the LaserCap clinical trial can find more information at http://www.844GetHair.com or call, 844-Get-Hair.

(*note: during the trial some participants may receive a non-working, “placebo” device)

About Dr. Alan J. Bauman:

Alan J. Bauman, M.D. is a full-time hair transplant surgeon who has treated over 17,000 patients and performed over 7,000 surgical procedures since starting his medical hair loss practice, Bauman Medical Group in 1997. Headquartered in sunny Boca Raton, Florida, Dr. Bauman received his M.D. degree from New York Medical College and surgical residency training at Mt. Sinai Medical Center and Beth Israel Medical Center in New York. Dr. Bauman is one of approximately 100 physicians worldwide to achieve the certification from the esteemed American and International Board of Hair Restoration Surgery, is an accepted member of the International Alliance of Hair Restoration Surgeons (IAHRS) and is also recommended by the American Hair Loss Association. Dr. Bauman has achieved Fellow status with the International Society of Hair Restoration Surgery (ISHRS) and is a frequently invited faculty member at numerous annual scientific meetings and live surgery workshops. He is an author of textbook chapters on the science of hair care and hair transplantation, including eyelash transplant surgery, and has been extensively featured in the world’s leading news media as a medical expert and successful early-adopter of some of the most advanced technologies in the treatment of hair loss such as laser therapy and minimally-invasive no-linear-scar NeoGraft FUE hair transplantation. Dr. Bauman also takes an active part in the Pantene Hair Research Institute, a global network of leading hair experts focused on the advancement of hair science, technologies and products. Personal appearances, interviews and profiles include the Today Show, The Early Show, Good Morning America, Extra, Access Hollywood, The Doctors and Dateline NBC among other TV appearances. Newspaper and Magazine articles and feature stories include The New York Times, Newsweek, Cosmo, Elle, Vogue, Allure, O – The Oprah Magazine and Men’s Health among others. For complete details visit http://www.BaumanMedical.com

Liz Ashe, Bauman Medical Group, http://www.baumanmedical.com, +1 561-465-7677, [email protected]

Modal title

LaserCap provides LLLT exposure to the entire scalp and fits discreetly under a hat.
LaserCap provides LLLT exposure to the entire scalp and fits discreetly under a hat.
LaserCap uses a flexible dome-shaped membrane
LaserCap uses a flexible dome-shaped membrane
LaserCap comes with 224 low level laser lights
LaserCap comes with 224 low level laser lights
LaserCap provides LLLT exposure to the entire scalp and fits discreetly under a hat. LaserCap uses a flexible dome-shaped membrane LaserCap comes with 224 low level laser lights

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.